BBioBody OSCardiovascular atlas ↗

CARDIOVASCULAR / PRESSURE

Pressure is an output,
not a single switch.

Arterial pressure emerges from cardiac output, vascular resistance, arterial properties, blood volume, kidney sodium handling, hormones, nerves, endothelium, and context. This map separates fast reflexes from slow volume regulation.

Play the narrated pressure flow See absolute outcome evidence

12-STAGE CONTROL MAP

Beat-to-beat control
meets kidney time.

A useful simplification is mean arterial pressure ≈ cardiac output × systemic vascular resistance, but pulsatility, arterial stiffness, wave reflection, posture, measurement conditions, and organ autoregulation also matter.

01SECONDS TO MINUTES
01

Pressure stretches sensors

Carotid-sinus and aortic-arch baroreceptors encode arterial stretch and relay it to the brainstem.

02

Autonomic response

Sympathetic and parasympathetic output adjusts heart rate, contractility, venous tone, and arteriolar tone.

03

Cardiac output changes

Rate and stroke volume alter blood delivered per minute.

04

Resistance redistributes flow

Arteriolar diameter changes systemic resistance while local tissues retain autoregulatory control.

02MINUTES TO DAYS
05

Kidney senses perfusion

Renal perfusion, tubular sodium delivery, and sympathetic signals influence renin release.

06

RAAS activates

Renin generates angiotensin signaling; angiotensin II supports vasoconstriction and aldosterone release.

07

Sodium and water shift

Aldosterone, ADH, thirst, and natriuretic peptides influence retained salt and water.

08

Volume changes venous return

Extracellular volume affects filling pressure, stroke volume, and pressure, with congestion if compensation overshoots.

03ENDOTHELIUM & LONG-TERM REMODELING
09

Nitric oxide relaxes

Endothelial NO activates smooth-muscle relaxation and helps match local flow to demand.

10

Endothelin constricts

Endothelin and other mediators can favor vasoconstriction; balance is local and context dependent.

11

Arteries remodel

Persistent load can produce wall thickening and stiffness, raising systolic load and pulse pressure.

12

Target organs accumulate injury

Chronic hypertension increases risk across brain, heart, kidneys, retina, and arteries even when symptoms are absent.

TREATMENT SITES

Different classes,
different control points.

Class choice and combinations depend on the clinical situation, other conditions, labs, pregnancy potential, adverse effects, and measured response.

RAAS

ACE inhibitors / ARBs

Reduce angiotensin signaling; monitoring can include kidney function and potassium.

VOLUME

Diuretics

Promote sodium excretion and lower volume/pressure; electrolyte and metabolic effects vary by class.

ARTERIOLES

Calcium-channel blockers

Selected drugs reduce vascular smooth-muscle contraction; edema and other effects vary.

HEART / NERVES

Beta blockers

Lower selected sympathetic effects and are especially useful for particular cardiac indications.

BEHAVIOR / CONTEXT

Foundational modifiers

Sodium pattern, dietary quality, alcohol, activity, sleep, weight, tobacco, and medication adherence can influence pressure.

MEASUREMENT

Confirm the signal

Validated cuff, correct size, rest, repeated readings, and out-of-office values help distinguish sustained pressure from noise.

Current guidance: 2025 AHA/ACC High Blood Pressure Guideline ↗ · Endothelial function review ↗

This model cannot diagnose hypertension or recommend an individual target. A hypertensive emergency is a clinical assessment, not a map state.